Cipla launches daptomycin for injection, 500 mg/vial
The single-dose vials are for intravenous use only
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Agilent introduces intelligent LC/MS system for chromatographers in India
The intuitive quadrupole incorporates 'designed-in' smart features
Eisai India and Mylan to commercialise teceris
The second eribulin brand in India, teceris aimed at expanding access to metastatic breast cancer patients in India
Lupin gets 3 observations from USFDA for its Tarapur facility
The inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September…
MyMedicineBox collaborates with Paytm First to help chronic patients
The service includes great savings upto 60 per cent on various needs of patients
USV to invest Rs 4,000 mn in new formulation plant at Vadodara
USV has three plants based in Daman and Baddi manufacturing tablets, capsules, sterile injectables and ophthalmic products, one…
Lupin appoints Jon Stelzmiller as President of US Specialty Business
He brings to Lupin over 30 years of experience in the specialty segment, and will be replacing Nicholas Hart
Cipla announces closure of USFDA inspection at Bengaluru facility
Following an inspection by USFDA at the company’s API manufacturing facility in Virgonagar, from July 15 to 19, the company has…
First patient randomised in a Phase 2A, Proof of Concept (PoC) clinical trial of SUVN-G3031
The trial is taking place for the treatment of Narcolepsy associated with or without Cataplexy in USA
Apollo Hospitals’ pharma biz rejig gets CCI clearance
Following the transaction, Apollo Pharmacy Ltd (APL) will be a wholly-owned subsidiary of Apollo Medicals Pvt Ltd (AMPL) in which…
Dr Reddy’s halts worldwide supply of ranitidine
USFDA probing into the reported impurity N-nitrosodimethylamine in it at low levels
Clariant inaugurates waste water treatment plant in Bonthapally
The plant can treat up to 300 kilolitres of waste water in a day, and treated water will be potable as per World Health…
Biocon subsidiary acquires research facility from Pfizer Healthcare
The facility is expected to be operational in a few months post qualification and will house over 250 scientists
Biocon said…
Indoco successfully completes UK-MHRA inspection at Goa Plant II
The Sterile manufacturing site is expected to receive the EU GMP certification soon, following this recent inspection, the company…
Zydus Cadila gets EIR from US FDA for Ankleshwar facility
The EIR report stated that the classification of the facility is "No Action Indicated (NAI)", the company added
US FDA issues one observation for Aleor Dermaceuticals’ Karakhadi unit
The regulator issued one observation after the inspection, as per reports
Torrent Pharma expands recall of hypertension drug in US
The company is expanding recall for Losartan potassium tablets USP and Losartan potassium / hydrochlorothiazide tablets to the…
Strides Board approves incremental investments in Stelis
It will accelerate Strides’ re-entry into sterile injectables business post the completion of the Company’s non-compete period in…
Inspection of Unichem’s Kolhapur facility by USFDA completed without observations
The inspection was a CGMP surveillance and a pre-approval inspection and was successfully concluded without any FDA Form 483…
Society for Pharmaceutical Science (SPDS) organises Disso India-Chandigarh 2019
Attended by more than 200 delegates from the industry and academia, the event comprised of plenary lectures, panel discussions,…